Navigation Links
When to Wait and When to Treat? New Program Will Search for Biomarkers in Men With Prostate Cancer to Help Find an Answer
Date:5/2/2008

SEATTLE, May 2 /PRNewswire/ -- Researchers at Fred Hutchinson Cancer Research Center have a lead role in a new public/private partnership to create the first systematic surveillance program of men with prostate cancer to look for biological clues to help determine when to wait and when to treat the disease. The project was announced by the Canary Foundation and the National Cancer Institute.

Peter Nelson, M.D., of the Hutchinson Center's Clinical Research and Human Biology divisions, will lead the Canary Prostate Consortium. This group of six institutions nationwide will enroll men in a cancer-surveillance study to look for biomarkers -- proteins in the blood that could predict prostate-tumor aggressiveness.

The new study is meant to help answer a key question that has vexed physicians and researchers: When is it best to treat prostate cancer versus observation or "watchful waiting." For most men with prostate cancer, the disease never progresses to become a serious health problem, yet most receive some sort of treatment, such as radiation or surgery. Such treatments can have side effects, such as impotence and incontinence, which can be worse than the low-grade cancer. Currently it is challenging to accurately predict when inactive or slow-growing prostate tumors will become aggressive.

"There's an emerging consensus that we dramatically over treat prostate cancer in general," said Nelson. "The overall prevalence of the disease in the population far exceeds the number of men whose disease progresses to cause serious problems. Yet, there are clearly many prostate cancers that behave aggressively and patients benefit from treatment. It is a challenging problem."

In the study, men diagnosed with early-stage prostate cancer will not be treated right away but will be closely followed in an active surveillance program involving regular collection of blood and urine samples as well as prostate biopsies. A new repository for blood and DNA
'/>"/>

SOURCE Fred Hutchinson Cancer Research Center
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Anesiva to Host Conference Call and Webcast Tomorrow to Discuss Encouraging Development in Zingo(TM) Program
2. Thermo Fisher Scientific Executive Officers Adopting SEC Rule 10b5-1 Trading Programs
3. SemBioSys updates Apo AI development program
4. SportCoatings; The North American Booster Club Association (NABCA); the Coatings Specialist Group New Booster Program Goes High Tech With Invisible Antimicrobial Defense
5. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
6. Sunesis Pharmaceuticals Announces Reorganization to Focus Resources and Build Value in Clinical-Stage Programs
7. NJ Board of Pharmacy Approves Wedgewood Pharmacy Technician-Training Program
8. Palatin Technologies Announces Reacquisition of Full Rights to Bremelanotide Program
9. Celebrity Designer Ty Pennington to Host ADHD Experts on Call Program
10. Diageo Sponsors Medical Society of the State of New Yorks Physicians Training Program
11. GlaxoSmithKline Awarded U.S. Department of Defense Contract to Pursue Novel Antibacterial Research Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2008)... 2 /- Aureus Pharma, a leading provid... discovery in the life science,industry, announced...will,be held in Paris on October 23rd and 24th., ...ul inaugural event,which was attended by many of A...oth Europe and North America. The symposium includ...
(Date:7/2/2008)...Advance Commercialization of Expanded Portfolio of... VANCOUVER, British Columbia, July 2 /PRNewswire/...tures Corp. (TSXV: MEV), a company developing and,...oday announced its name,change and the expansion o...the acquisition of two vascular product developmen...
(Date:7/2/2008)...oints to potential of pre-treatment R2 levels as a... activity -, TORONTO, July 2 /PRNewswire-FirstCal... ("Lorus" or the "Corporation"), a biopharmaceutic...pment of pharmaceutical products and,technologies ...ication by,an Ohio State University (OSU) clinical...
(Date:7/1/2008)... N.J., July 2 /- Schering-P...e successful closing of its,previously announced t...th,products from selected franchises. These divest... part of its October 2007 clearance of the,acquisi...ac acquired products from the endocrine, mastitis ...
Breaking Biology Technology:Aureus Pharma Announces Date of 2008 Annual User Symposium 2Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing 2Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing 3Medical Ventures Becomes Neovasc with Two Corporate Acquisitions and $8.3 Million Financing 4Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 2Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 3Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 4Lorus Therapeutics Announces Publication of a Clinical Study Demonstrating Encouraging Results with LOR-2040 in Combination with Cytarabine in Patients with Acute Myeloid Leukemia (AML) 5Schering-Plough Announces Closing of Planned Divestiture of Selected Animal Health Products 2
... Isolate and Enrich for Bacterial mRNA ,...icroarray Analysis , The rapid increase i...omes sequenced over the past , ...ome , expression analysis using... years, this tool has been used to explore...
... , No more siRNA design a... complete in 1 day , ...paration, RNase , III digestion and siR... Silencing Experiments The , ...) to induce targeted gene , sil...
...t Full-length cDNA , Ambion scientists ...nscriptase , to improve production of ful...se, , <A , href="http:...ipt , (patent pending), produces signifi...A than wild type RTs, and rivals even the newest e...
...bion now offers a complete Gene Expression Profili...s. From basic data analysis to our Full Service of...all. The Full Service offering includes , c...y and informatics scientists , and comprehe...iding innovative, , high quality products a...
Other Biology Technology:Bacterial Whole Genome Array Analysis 2Bacterial Whole Genome Array Analysis 3Bacterial Whole Genome Array Analysis 4Bacterial Whole Genome Array Analysis 5Bacterial Whole Genome Array Analysis 6Bacterial Whole Genome Array Analysis 7Avoid siRNA Design Altogether! 2Avoid siRNA Design Altogether! 3ArrayScript RT: Maximize Yields of Full-length cDNA 2ArrayScript RT: Maximize Yields of Full-length cDNA 3Ambion Offers Gene Expression Profiling Service 2Ambion Offers Gene Expression Profiling Service 3
(Date:7/2/2008)...want to produce a lot of a substance -- such as a ...s, molecules that speed chemical reactions. Many j...ing one in just the right shape to connect with ce...s, such as enzymes in the human body that help us ...ting to suit the task at hand. , Chemists have m...
(Date:7/2/2008)...erman . , Metabolomics aims to determine the tot.... The exponents of bioinformatics analyzed data co...omics study in healthy and diabetic mice. In each ...he diabetes drug RoziglitazoneTM. Then, more than ...a blood plasma sample of a total of forty mice, re...
(Date:7/2/2008)...Spanish . , Most of the functions performed by ...eins, which recognise their binding partner by aff...here are many kinds of interactions; however, the ...structural biology are those which are transient. ...gh a large section of the protein surface- the glo...
(Date:7/2/2008)... of its kind, using sophisticated methods to measu...al weight loss program, Weight Watchers, was compa...ethod wins in the game of good health. A Universit...periences of participants to determine which progr...ain health benefits. The answer is that both have ...
Breaking Biology News(10 mins):Synthetic molecules emulate enzyme behavior for the first time 2Synthetic molecules emulate enzyme behavior for the first time 3Healthy or diseased? 2Scientists reveal the key mechanisms for affinity between transient binding proteins 2Weight Watchers vs. fitness centers 2Flexible Medical Systems Raises 241 2M Seed Investment for Initial Human Trials 350 1Flexible Medical Systems Raises 241 2M Seed Investment for Initial Human Trials 350 2Biodel Inc Expands Ongoing Phase III VIAject 28TM 29 Clinical Trials Into Europe 347 1Biodel Inc Expands Ongoing Phase III VIAject 28TM 29 Clinical Trials Into Europe 347 2Biodel Inc Expands Ongoing Phase III VIAject 28TM 29 Clinical Trials Into Europe 347 3Teenage Drinking Can Spell Lasting Trouble 1742 1Teenage Drinking Can Spell Lasting Trouble 1742 2Teenage Drinking Can Spell Lasting Trouble 1742 3Pathway to cell death redefined in landmark study 1739 1Pathway to cell death redefined in landmark study 1739 2Pathway to cell death redefined in landmark study 1739 3Pathway to cell death redefined in landmark study 1739 4
...fied a cell population that is a primary target of...poral dementia, which is as common as Alzheimer,s ...e 65. , Because the cells arose only recently in ...eat apes and humans-- and are particularly abundan...that evolution has rendered the human brain vulner...
... an antibiotic in a non-native host has provided a... at Urbana-Champaign with the potential for develo...e rapid rise of antibiotic resistance poses a seri...ents effective against resistant pathogens. Fosfom...and Drug Administration for the treatment of vario...
...ffer hearing loss due to the toxic effects of chem...g back through pharmacological and gene therapy, t...hildren,s Research Hospital. Mice with a variety o...f the ear will also help scientists understand age...g loss caused by long-term exposure to loud noise,...
...from global warming? Perhaps, but the tradeoffs in...uclear waste generated each year and a greatly inc...version of nuclear material into terrorists, hands... Rodney Ewing, who has analyzed just how much nucl...ly reduce greenhouse gas emissions worldwide, and ...
Other Biology News:Study offers window into human behavior, brain disease 2Study offers window into human behavior, brain disease 3Study offers window into human behavior, brain disease 4Cloning techniques produce FDA-approved antibiotic 2St. Jude finds clues to hearing loss from chemotherapy 2Plutonium or greenhouse gases? Weighing the energy options 2
RABBIT ANTI HUMAN TRRAP (CT) Immunogen: Recombinant C-terminal kinase-related domain of human TRRAP.
Edited by D. Rickwood, T.C. Ford and J.T. Steensgaard (1994) Compiles core data required by researchers carrying out any centrifugal separation, whether working with cells, organelles or macromolec
MOUSE ANTI PROTEIN KINASE C BETA 2 Immunogen: Protein kinase C beta 2
The Captivate magnetic separator for six microtubes can be used in conjunction with the Captivate ferrofluid conjugates (C-21473, C-21474, C-21476) or other magnetic particles and can accommodate s
Biology Products: